The prospective trajectory of exosomes-based cancer nanomedicine

Abstract

Extracellular vesicles (EVs), including exosomes, ectosomes, and apoptotic bodies, play crucial roles in cellular communication and disease processes. Among these, exosomes are particularly significant for diagnosing, and cancer (which remains a leading cause of death worldwide). Exosomes offer cutting-edge approaches in cancer nanomedicine, cancer biomarkers investigation (diagnosis and prognosis), and therapeutic. Exosomes are found in several body fluids (Blood, plasma, serum, urine, saliva, sweat, CSF, tear). It transforms the liquid biopsy method with more specificity. Exosome-based sensor (electrochemical and aptamer-based) developers were more effective and sensitive for cancer scanning. Therapeutic prospect stem cell-derived exosomes, and plant-derived exosomes become more promising. Due to its non-toxicity (depending on the source), non-immunogenic, biocompatibility and ability to cross biological membranes. Exosomes are an exciting nano-drug transporter with specificity. Current time-modified exosomes support to development of effective, efficient, and cost-effective nanomedicine against cancer. Advanced nanotechnology and exosome combining (single exosome profiling, exosome barcoding)transform cancer theranostics approaches. Exosomes introduce a new horizon of cancer nanomedicine.

Keywords

cancer / exosomes / nanomedicine / sensor / therapeutic

References

[1] Shivji GG, Dhar R, Devi A. Role of exosomes and its emerging therapeutic applications in the pathophysiology of non-infectious diseases. Biomarkers. 2022;27(6):534-548.

[2] Agnihotram R, Dhar R, Dhar D, et al. Fusion of exosomes and nanotechnology: cutting-edge cancer theranostics. ACS Appl Nano Mater. 2024;7(8):8489-8506.

[3] Cano A, Muñoz-Morales Á, Sánchez-López E, et al. Exosomes-based nanomedicine for neurodegenerative diseases: current insights and future challenges. Pharmaceutics. 2023;15(1):298.

[4] Li YJ, Wu JY, Liu J, et al. Artificial exosomes for translational nanomedicine. J Nanobiotechnol. 2021;19(1):242.

[5] Mehata AK, Gupta N, Muthu MS. Exosomes as a novel nanomedicine platform for personalized triple-negative breast cancer therapy. Nanomedicine. 2023;18(6):501-504.

[6] Delcayre A, Estelles A, Sperinde J, et al. Exosome Display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol Dis. 2005;35(2):158-168.

[7] Sen S, Xavier J, Kumar N, et al. Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives. 3 Biotech. 2023;13(3):101.

[8] Soo CY, Song Y, Zheng Y, et al. Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology. 2012;136(2):192-197.

[9] daFonseca Alves R, Pallarès-Rusiñol A, Rossi R, et al. Peptide-based biosensing approaches for targeting breast cancer-derived exosomes. Biosens Bioelectron. 2024;255:116211.

[10] Sözmen AB, Arslan-Yildiz A. Utilizing magnetic levitation to detect lung cancer-associated exosomes. ACS Sens. 2024;9(4):2043-2049.

[11] Ramachandran A, Dhar R, Devi A. Stem cell-derived exosomes: an advanced horizon to cancer regenerative medicine. ACS Appl Bio Mater. 2024;7(4):2128-2139.

[12] Ansari MA, Thiruvengadam M, Venkidasamy B, et al. Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: current status and future perspectives. Semin Cancer Biol. 2022;86(Pt. 2):678-696.

[13] Zhao M, Li Q, Zhao Y, et al. Dual-aptamer recognition of DNA logic gate sensor-based specific exosomal proteins for ovarian cancer diagnosis. ACS Sens. Published online: Apr 18, 2024.

[14] Syn NL, Wang L, Chow EK, et al. Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends Biotechnol. 2017;35(7):665-676.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.